---
title: "Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251003846.md"
description: "Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ..."
datetime: "2025-07-31T12:37:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251003846.md)
  - [en](https://longbridge.com/en/news/251003846.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251003846.md)
---

# Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors ...

### Related Stocks

- [GLYC.US](https://longbridge.com/en/quote/GLYC.US.md)
- [CBIO.US](https://longbridge.com/en/quote/CBIO.US.md)

## Related News & Research

- [Top Stock Picks of 2026: DigitalOcean Holdings](https://longbridge.com/en/news/282347811.md)
- [The unconventional logic behind SpaceX's $1.75 trillion price tag](https://longbridge.com/en/news/282332945.md)
- [SEM Holdings’ Controlling Shareholder Cuts Stake but Retains Control](https://longbridge.com/en/news/282758128.md)
- [Prediction: QuantumScape (QS) Stock Is a Buy Before April 22](https://longbridge.com/en/news/282315819.md)
- [Is It Time To Revisit Zscaler (ZS) After Its Recent Share Price Slide](https://longbridge.com/en/news/282296165.md)